OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

2.41
Delayed Data
As of Mar 02
 +0.115 / +5.01%
Today’s Change
1.92
Today|||52-Week Range
14.25
+5.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-12.6M-14.7M-21.1M-31.8M
 
 
 
 
 
Depreciation52.0K75.0K100.0K227.0K
 
 
 
 
 
Total Other Cash Flow5.6M-6.2M-4.1M-3.0M
 
 
 
 
 
Funds From Operations-6.9M-20.8M-25.1M-34.7M
 
 
 
 
 
Funds From/For Other Operating Expenses19.9M-535.0K18.4M1.3M
 
 
 
 
 
Net Cash Flow - Operating Activities-26.8M-20.3M-43.5M-35.9M
 
 
 
 
 
 
InvestingIncrease In Investments-93.0M-75.1M-110.4M-31.7M
 
 
 
 
 
Decrease In Investments34.0M100.3M89.5M64.4M
 
 
 
 
 
Capital Expenditures-68.0K-79.0K-291.0K-253.0K
 
 
 
 
 
Net Cash Flow Investing-59.1M25.1M-21.2M32.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale47.5M219.0K54.2M10.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing47.5M219.0K54.2M10.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-33.0K-40.0K0.009.0K
 
 
 
 
 
Net Change In Cash-38.5M5.0M-10.4M-3.5M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account